Life Insurance Corporation of India (NSE: LICI.NS) Stock Competitors & Peer Comparison

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, LICI.BO has a market cap of 5.3T. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while LICI.BO trades at ₹422.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas LICI.BO's P/E ratio is 12.01. In terms of profitability, LICI.NS's ROE is +0.18%, compared to LICI.BO's ROE of +0.18%. Regarding short-term risk, LICI.NS is similarly volatile compared to LICI.BO. This indicates similar risk in terms of short-term price fluctuations for LICI.NS.Check LICI.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, SBILIFE.BO has a market cap of 1.8T. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while SBILIFE.BO trades at ₹1,763.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas SBILIFE.BO's P/E ratio is 68.10. In terms of profitability, LICI.NS's ROE is +0.18%, compared to SBILIFE.BO's ROE of +0.14%. Regarding short-term risk, LICI.NS is less volatile compared to SBILIFE.BO. This indicates lower risk in terms of short-term price fluctuations for LICI.NS.Check SBILIFE.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, SBILIFE.NS has a market cap of 1.8T. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while SBILIFE.NS trades at ₹1,761.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas SBILIFE.NS's P/E ratio is 68.02. In terms of profitability, LICI.NS's ROE is +0.18%, compared to SBILIFE.NS's ROE of +0.14%. Regarding short-term risk, LICI.NS is less volatile compared to SBILIFE.NS. This indicates lower risk in terms of short-term price fluctuations for LICI.NS.Check SBILIFE.NS's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, HDFCLIFE.NS has a market cap of 1.2T. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while HDFCLIFE.NS trades at ₹552.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas HDFCLIFE.NS's P/E ratio is 62.48. In terms of profitability, LICI.NS's ROE is +0.18%, compared to HDFCLIFE.NS's ROE of +0.11%. Regarding short-term risk, LICI.NS is more volatile compared to HDFCLIFE.NS. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check HDFCLIFE.NS's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, HDFCLIFE.BO has a market cap of 1.2T. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while HDFCLIFE.BO trades at ₹550.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas HDFCLIFE.BO's P/E ratio is 61.97. In terms of profitability, LICI.NS's ROE is +0.18%, compared to HDFCLIFE.BO's ROE of +0.11%. Regarding short-term risk, LICI.NS is more volatile compared to HDFCLIFE.BO. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check HDFCLIFE.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, ICICIPRULI.BO has a market cap of 743.9B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while ICICIPRULI.BO trades at ₹513.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas ICICIPRULI.BO's P/E ratio is 44.01. In terms of profitability, LICI.NS's ROE is +0.18%, compared to ICICIPRULI.BO's ROE of +0.12%. Regarding short-term risk, LICI.NS is less volatile compared to ICICIPRULI.BO. This indicates lower risk in terms of short-term price fluctuations for LICI.NS.Check ICICIPRULI.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, ICICIPRULI.NS has a market cap of 741.2B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while ICICIPRULI.NS trades at ₹511.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas ICICIPRULI.NS's P/E ratio is 44.19. In terms of profitability, LICI.NS's ROE is +0.18%, compared to ICICIPRULI.NS's ROE of +0.12%. Regarding short-term risk, LICI.NS is less volatile compared to ICICIPRULI.NS. This indicates lower risk in terms of short-term price fluctuations for LICI.NS.Check ICICIPRULI.NS's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, MFSL.BO has a market cap of 546.6B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while MFSL.BO trades at ₹1,568.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas MFSL.BO's P/E ratio is 288.88. In terms of profitability, LICI.NS's ROE is +0.18%, compared to MFSL.BO's ROE of +0.02%. Regarding short-term risk, LICI.NS is less volatile compared to MFSL.BO. This indicates lower risk in terms of short-term price fluctuations for LICI.NS.Check MFSL.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, MFSL.NS has a market cap of 541.8B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while MFSL.NS trades at ₹1,569.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas MFSL.NS's P/E ratio is 343.04. In terms of profitability, LICI.NS's ROE is +0.18%, compared to MFSL.NS's ROE of +0.02%. Regarding short-term risk, LICI.NS is more volatile compared to MFSL.NS. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check MFSL.NS's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, STARHEALTH.BO has a market cap of 339.4B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while STARHEALTH.BO trades at ₹572.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas STARHEALTH.BO's P/E ratio is 60.89. In terms of profitability, LICI.NS's ROE is +0.18%, compared to STARHEALTH.BO's ROE of +0.10%. Regarding short-term risk, LICI.NS is more volatile compared to STARHEALTH.BO. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check STARHEALTH.BO's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, STARHEALTH.NS has a market cap of 337.2B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while STARHEALTH.NS trades at ₹573.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas STARHEALTH.NS's P/E ratio is 60.51. In terms of profitability, LICI.NS's ROE is +0.18%, compared to STARHEALTH.NS's ROE of +0.10%. Regarding short-term risk, LICI.NS is more volatile compared to STARHEALTH.NS. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check STARHEALTH.NS's competition here

Life Insurance Corporation of India (NSE: LICI.NS) plays a significant role within the Financial Services sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LICI.NS stands at 5.3T. In comparison, NIVABUPA.NS has a market cap of 152.6B. Regarding current trading prices, LICI.NS is priced at ₹421.85 on the NSE, while NIVABUPA.NS trades at ₹82.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LICI.NS currently has a P/E ratio of 6.73, whereas NIVABUPA.NS's P/E ratio is 69.23. In terms of profitability, LICI.NS's ROE is +0.18%, compared to NIVABUPA.NS's ROE of +0.09%. Regarding short-term risk, LICI.NS is more volatile compared to NIVABUPA.NS. This indicates higher risk in terms of short-term price fluctuations for LICI.NS.Check NIVABUPA.NS's competition here